WallStreetZenWallStreetZen

NYSE: ZBH
Zimmer Biomet Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ZBH

Based on 13 analysts offering 12 month price targets for Zimmer Biomet Holdings Inc

Min Forecast
$86.00-8.62%
Avg Forecast
$104.23+10.75%
Max Forecast
$130.00+38.14%

Should I buy or sell ZBH stock?

Based on 13 analysts offering ratings for Zimmer Biomet Holdings Inc.

Hold
Strong Buy
3 analysts 23.08%
Buy
2 analysts 15.38%
Hold
6 analysts 46.15%
Sell
0 analysts 0%
Strong Sell
2 analysts 15.38%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their ZBH stock forecasts and price targets.

ZBH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-12
lockedlocked$00.00+00.00%2026-02-11
lockedlocked$00.00+00.00%2026-02-11
lockedlocked$00.00+00.00%2026-02-10
lockedlocked$00.00+00.00%2026-01-28
Bernstein
Top 33%
68
HoldMaintains$99.00+5.20%2026-01-09
Evercore ISI Group
Bottom 5%
5
BuyUpgrades$120.00+27.51%2026-01-05
Baird
Top 19%
82
HoldDowngrades$100.00+6.26%2025-12-16
Canaccord Genuity
Bottom 23%
23
HoldMaintains$93.00-1.18%2025-11-10
RBC Capital
Top 26%
75
BuyMaintains$101.00+7.32%2025-11-06

1 of 2

Forecast return on equity

Is ZBH forecast to generate an efficient return?

Company
15.88%
Industry
30.01%
Market
181.35%
ZBH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZBH forecast to generate an efficient return on assets?

Company
8.73%
Industry
15.09%
ZBH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZBH earnings per share forecast

What is ZBH's earnings per share in the next 3 years based on estimates from 31 analysts?

Avg 1 year Forecast
$8.48+138.17%
Avg 2 year Forecast
$9.09+155.29%
Avg 3 year Forecast
$9.64+170.84%
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ZBH revenue forecast

What is ZBH's revenue in the next 3 years based on estimates from 31 analysts?

Avg 1 year Forecast
$8.6B+4.93%
Avg 2 year Forecast
$9.0B+8.83%
Avg 3 year Forecast
$9.3B+12.66%
ZBH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZBH earnings growth forecast

How is ZBH forecast to perform vs Medical Devices companies and vs the US market?

Company
39.46%
Industry
24.24%
Market
36.44%
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ZBH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ZBH revenue growth forecast

How is ZBH forecast to perform vs Medical Devices companies and vs the US market?

Company
4.06%
Industry
9.01%
Market
13.44%
ZBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZBH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZBH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ZBH$94.11$104.23+10.75%Hold
PODD$237.01$358.33+51.19%Strong Buy
SNN$34.31$35.00+2.01%Hold
STE$230.51N/AN/A
PEN$338.64$371.46+9.69%Buy
View Top Medical Device Stocks

Zimmer Biomet Holdings Stock Forecast FAQ

Is Zimmer Biomet Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: ZBH) stock is to Hold ZBH stock.

Out of 13 analysts, 3 (23.08%) are recommending ZBH as a Strong Buy, 2 (15.38%) are recommending ZBH as a Buy, 6 (46.15%) are recommending ZBH as a Hold, 0 (0%) are recommending ZBH as a Sell, and 2 (15.38%) are recommending ZBH as a Strong Sell.

If you're new to stock investing, here's how to buy Zimmer Biomet Holdings stock.

What is ZBH's earnings growth forecast for 2026-2028?

(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual earnings growth rate of 39.46% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.24%, and it is also forecast to beat the US market's average forecast earnings growth rate of 36.44%.

Zimmer Biomet Holdings's earnings in 2026 is $705,100,000.On average, 31 Wall Street analysts forecast ZBH's earnings for 2026 to be $1,658,913,777, with the lowest ZBH earnings forecast at $1,600,824,697, and the highest ZBH earnings forecast at $1,733,868,059. On average, 29 Wall Street analysts forecast ZBH's earnings for 2027 to be $1,778,163,673, with the lowest ZBH earnings forecast at $1,654,707,259, and the highest ZBH earnings forecast at $2,002,987,391.

In 2028, ZBH is forecast to generate $1,886,476,623 in earnings, with the lowest earnings forecast at $1,698,807,220 and the highest earnings forecast at $2,046,128,658.

What is ZBH's revenue growth forecast for 2026-2028?

(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 4.06% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.44%.

Zimmer Biomet Holdings's revenue in 2026 is $8,231,500,000.On average, 31 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,689,846,358,548, with the lowest ZBH revenue forecast at $1,618,237,725,084, and the highest ZBH revenue forecast at $1,772,411,504,236. On average, 30 Wall Street analysts forecast ZBH's revenue for 2027 to be $1,752,650,651,832, with the lowest ZBH revenue forecast at $1,668,128,986,104, and the highest ZBH revenue forecast at $1,854,194,041,908.

In 2028, ZBH is forecast to generate $1,814,476,685,096 in revenue, with the lowest revenue forecast at $1,700,802,870,772 and the highest revenue forecast at $1,938,128,751,624.

What is ZBH's forecast return on assets (ROA) for 2026-2029?

(NYSE: ZBH) forecast ROA is 8.73%, which is lower than the forecast US Medical Devices industry average of 15.09%.

What is ZBH's Price Target?

According to 13 Wall Street analysts that have issued a 1 year ZBH price target, the average ZBH price target is $104.23, with the highest ZBH stock price forecast at $130.00 and the lowest ZBH stock price forecast at $86.00.

On average, Wall Street analysts predict that Zimmer Biomet Holdings's share price could reach $104.23 by Feb 12, 2027. The average Zimmer Biomet Holdings stock price prediction forecasts a potential upside of 10.75% from the current ZBH share price of $94.11.

What is ZBH's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: ZBH) Zimmer Biomet Holdings's current Earnings Per Share (EPS) is $3.56. On average, analysts forecast that ZBH's EPS will be $8.48 for 2026, with the lowest EPS forecast at $8.18, and the highest EPS forecast at $8.86. On average, analysts forecast that ZBH's EPS will be $9.09 for 2027, with the lowest EPS forecast at $8.46, and the highest EPS forecast at $10.24. In 2028, ZBH's EPS is forecast to hit $9.64 (min: $8.68, max: $10.46).

What is ZBH's forecast return on equity (ROE) for 2026-2029?

(NYSE: ZBH) forecast ROE is 15.88%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.